{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T06:09:29Z","timestamp":1769753369615,"version":"3.49.0"},"reference-count":32,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T00:00:00Z","timestamp":1355270400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0049894","type":"journal-article","created":{"date-parts":[[2012,12,12]],"date-time":"2012-12-12T22:10:28Z","timestamp":1355350228000},"page":"e49894","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":28,"title":["Ability of Procalcitonin to Discriminate Infection from Non-Infective Inflammation Using Two Pleural Disease Settings"],"prefix":"10.1371","volume":"7","author":[{"given":"Fiona J.","family":"McCann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J.","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wai Cho","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick A.","family":"Maskell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J. O.","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y. C. Gary","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2012,12,12]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1378\/chest.11-2430","article-title":"Role of procalcitonin in managing adult patients with respiratory tract infections","volume":"141","author":"P Schuetz","year":"2012","journal-title":"Chest"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1097\/CCM.0B013E318165BABB","article-title":"Procalcitonin assay in systemic inflammation, infection, and sepsis: clinical utility and limitations","volume":"36","author":"KL Becker","year":"2008","journal-title":"Crit Care Med"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1515\/CCLM.1999.119","article-title":"Molecular aspects and natural source of procalcitonin","volume":"37","author":"S Russwurm","year":"1999","journal-title":"Clin Chem Lab Med"},{"key":"ref4","first-page":"243","article-title":"Value of procalcitonin quick test in the differentiation between sterile and infected forms of acute pancreatitis","volume":"52","author":"A Olah","year":"2005","journal-title":"Hepatogastroenterology"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1097\/00003246-199910000-00016","article-title":"Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin","volume":"27","author":"FM Brunkhorst","year":"1999","journal-title":"Crit Care Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.ccc.2011.01.002","article-title":"Biomarkers in the critically ill patient: procalcitonin","volume":"27","author":"K Reinhart","year":"2011","journal-title":"Crit Care Clin"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S1473-3099(07)70052-X","article-title":"Accuracy of procalcitonin for sepsis diagnosis in critically ill patients: systematic review and meta-analysis","volume":"7","author":"BM Tang","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1378\/chest.09-2920","article-title":"ProHOSP Study Group Procalcitonin levels predict bacteremia in patients with community-acquired pneumonia: a prospective cohort trial","volume":"1381","author":"F M\u00fcller","year":"2010","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1007\/s00134-011-2189-1","article-title":"Can procalcitonin help identify associated bacterial infection in patients with severe influenza pneumonia? A multicentre study","volume":"375","author":"E Cuquemelle","year":"2011","journal-title":"Intensive Care Med"},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Davies HE, Lee YCG (2008) Pleural Effusion, Empyema and Pneumothorax. In: Albert RK, Spiro SG, Jett JR, eds. Clinical Pulmonary Medicine. Philadelphia, PA, USA: Elsevier.853\u201367.","DOI":"10.1016\/B978-032304825-5.10069-8"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1097\/MCP.0b013e328352c673","article-title":"<italic>Pleural infection - what we need to know but don&apos;t<\/italic>","volume":"18","author":"C Tobin","year":"2012","journal-title":"Curr Opin Pulm Med"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/01.mcp.0000129756.87090.55","article-title":"Pleurodeses for malignant pleural effusions: current controversies and variations in practices","volume":"10","author":"SD West","year":"2004","journal-title":"Curr Opin Pulm Med"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1440-1843.2004.00566.x","article-title":"Management of malignant pleural effusions","volume":"9","author":"YCG Lee","year":"2004","journal-title":"Respirology"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1056\/NEJMoa042473","article-title":"U.K. Controlled trial of intrapleural streptokinase for pleural infection","volume":"352","author":"NA Maskell","year":"2005","journal-title":"N Engl J Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1164\/rccm.200311-1579OC","article-title":"Prospective randomized trials comparing the influence of talc of different particle sizes and tetracycline on lung and systemic inflammation after pleurodesis","volume":"170","author":"NA Maskell","year":"2004","journal-title":"Am J Respir Crit Care Med"},{"key":"ref16","first-page":"518","article-title":"The primary result of the Second UK Multi-Centre Intrapleural Sepsis Trial (MIST2): A randomised controlled trial of adjuvant intra-pleural recombinant tissue plasminogen activator and recombinant deoxyribonucleic acidase in pleural infection","volume":"365","author":"NM Rahman","year":"2011","journal-title":"New Engl J Med"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1378\/chest.126.6.2022","article-title":"Diagnostically significant variations in pleural fluid pH in loculated parapneumonic effusions","volume":"126","author":"NA Maskell","year":"2004","journal-title":"Chest"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1097\/01.CCM.0000226413.54364.36","article-title":"Procalcitonin as a diagnostic test for sepsis in critically ill adults and after surgery or trauma: a systematic review and meta-analysis","volume":"34","author":"B Uzzan","year":"2006","journal-title":"Crit Care Med"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1007\/s15010-001-1165-z","article-title":"Predictive value of serum and cerebrospinal fluid procalcitonin levels for the diagnosis of bacterial meningitis","volume":"29","author":"M Jereb","year":"2001","journal-title":"Infection"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1365-2362.2008.01935.x","article-title":"Severe aseptic inflammation caused by long distance running (246 km) does not increase procalcitonin","volume":"38","author":"I Papassotiriou","year":"2008","journal-title":"Eur J Clin Invest"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1189\/jlb.72.4.643","article-title":"High circulating levels of the IL-1 type II decoy receptor in critically ill patients with sepsis: association of high decoy receptor levels with glucocorticoid administration","volume":"72","author":"B M\u00fcller","year":"2002","journal-title":"J Leukoc Biol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1007\/s00134-007-0955-x","article-title":"The influence of corticosteroids on the release of novel biomarkers in human endotoxemia","volume":"343","author":"MD de Kruif","year":"2008","journal-title":"Intensive Care Med"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Sahn SA, Heffner JE (2008) Pleural fluid analysis. In: Light RW, Lee YCG, eds. Textbook of Pleural Diseases. London, U.K.: Arnold Press.209\u201326.","DOI":"10.1201\/b13502-20"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Rahman NM, Davies RJO (2008) Parapneumonic effusion and empyema. In: Light RW, Lee YCG, eds. Textbook of Pleural Diseases, 2nd ed. London, U.K.: Arnold Press.341\u201366.","DOI":"10.1201\/b13502-29"},{"key":"ref25","first-page":"ii4","article-title":"The British Thoracic Society Guidelines for the investigation of a unilateral pleural effusion in adults","volume":"65","author":"C Hooper","year":"2010","journal-title":"Thorax"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1183\/09059180.00005610","article-title":"Empyema Thoracic \u2013 new insights into an old disease","volume":"19","author":"FJ Brims","year":"2010","journal-title":"Eur Respir Rev"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1378\/chest.08-1134","article-title":"Diagnostic and prognostic value of pleural fluid procalcitonin in parapneumonic pleural effusions","volume":"136","author":"MC Lin","year":"2009","journal-title":"Chest"},{"key":"ref28","doi-asserted-by":"crossref","first-page":"398","DOI":"10.3346\/jkms.2009.24.3.398","article-title":"Serum and pleural fluid procalcitonin in predicting bacterial infection in patients with parapneumonic effusion","volume":"24","author":"YC Ko","year":"2009","journal-title":"J Koream Med Sci"},{"key":"ref29","article-title":"Biomarkers of infection for the differential diagnosis of pleural effusions","author":"JM Porcel","year":"2009","journal-title":"Eur Respir J"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10096-010-1082-0","article-title":"Diagnostic value of procalcitonin in pleural effusions","volume":"30","author":"CY Wang","year":"2011","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2310\/JIM.0b013e3181f88648","article-title":"Procalcitonin, C-reactive protein, and cell counts in the diagnosis of parapneumonic pleural effusions","volume":"58","author":"ME San Jos\u00e9","year":"2010","journal-title":"J Investig Med"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/cid\/cir408","article-title":"Procalcitonin to guide duration of antimicrobial therapy in intensive care units: a systematic review","volume":"53","author":"R Agarwal","year":"2011","journal-title":"Clin Infect Dis"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0049894","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:56:00Z","timestamp":1687892160000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0049894"}},"subtitle":[],"editor":[{"given":"T. Mark","family":"Doherty","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2012,12,12]]},"references-count":32,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2012,12,12]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0049894","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,12,12]]}}}